Agreement for the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine during a pandemic
A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 10 year (est.)
- Value
- £1
- Sector
- HEALTH
- Published
- 26 Sep 2023
- Delivery
- To 04 Aug 2033 (est.)
- Deadline
- n/a
Concepts
Location
London






2 buyers
1 supplier
- Seqirus Maidenhead
Description
Advance Purchase Agreement for Influenza Pandemic Specific Vaccines
Total Quantity or Scope
For the reservation of manufacturing capacity and production and supply of influenza pandemic specific vaccine in the event of a pandemic.
Award Detail
1 | Seqirus (Maidenhead)
|
Renewal Options
The contract has the option to be extended for up to 6 years in fixed increments of 2 years at a time (i.e. 4+2+2+2). The total contract term including any extensions will not exceed 10 years.
Award Criteria
Clinical / Scientific Evidence | 25.0 |
UK Manufacturing Diversification | 4.0 |
Risk Allocation | 12.0 |
Timeliness & Capacity | 8.0 |
Performance | 3.0 |
Manufacture & Logistics | 11.0 |
Product Administration | 2.0 |
Social Value | 10.0 |
Legal Risk | 5.0 |
Cost | 20.0 |
CPV Codes
- 33651660 - Influenza vaccines
Indicators
- Options are available.
- Award on basis of price and quality.
Other Information
Information on the contract value has been withheld pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interests of the supplier.The contract is for the benefit of the Authority & NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments & their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies & British Overseas Territories including without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies & British Overseas Territories to undertake their respective vaccination programmes.
Reference
- FTS 028287-2023